Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair. The Company has a broad pipeline of programs to address multiple CNS disorders. In April 2023, Pipeline announced that it entered into a global license and development agreement with Janssen Pharmaceutica NV (Janssen) for its lead program, PIPE-307, a highly selective M1 antagonist, in central nervous system disorders. The Company’s second program, PIPE-791, an LPA1 receptor antagonist, has received FDA clearance of its IND and is advancing into Phase 1 testing.
View Top Employees from Pipeline Therapeutics| Website | http://www.pipelinetherapeutics.com/ |
| Employees | 34 (33 on RocketReach) |
| Founded | 2017 |
| Phone | +1 858-333-5280 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceutical, Health Care |
Looking for a particular Pipeline Therapeutics employee's phone or email?
Pipeline Therapeutics Questions
Peter Slover is the CFO of Pipeline Therapeutics.
33 people are employed at Pipeline Therapeutics.
Pipeline Therapeutics is based in San Diego, California.
Top Pipeline Therapeutics Employees
-
34
-
View
Daniel Lorrain
Chief Scientific Officer at Pipeline Therapeutics
San Diego, California, United States24 -
View
Faans Stephen L. Huhn
CMO and SVP, Clinical Development at Pipeline Therapeutics
California, United States23 -
ViewDaniel Lorrain
Founder and Chief Scientific Officer at Pipeline Therapeutics
San Diego, California, United States5+5 -
2
-
11
-
32
-
33
-
1
Related Companies
